Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The United Kingdom AI in healthcare market was valued at USD 11.14 Billion in 2025 and is expected to grow at a CAGR of 36.70%, reaching USD 253.85 Billion by 2035. The market growth is driven by advanced digital infrastructure and the increasing adoption of AI-driven diagnostics and clinical decision tools. The widespread implementation of healthcare digitalization, increasing investments in precision medicine, and growing integration of automation across hospitals are expected to accelerate market expansion during the forecast period.
The Iran-US-Israel conflict that escalated in late February 2026 is creating significant disruptions for the United Kingdom AI in Healthcare Market, a sector valued at over USD 11 billion in 2025 and growing at a CAGR of nearly 38%. The UK Government's ambition to make the NHS the most AI-enabled care system in the world faces new obstacles as the conflict drives up energy costs, disrupts global AI infrastructure, and threatens the supply of advanced semiconductors and cloud computing resources essential for healthcare AI deployment.
Rising energy costs represent the most immediate challenge. UK wholesale natural gas prices have risen by approximately 75% between late February and late March 2026, directly increasing the operational costs of AI data centres that power healthcare applications such as diagnostic imaging, clinical decision support, and administrative automation. AI workloads in healthcare are computationally intensive, requiring substantial power for training and inference. Higher energy costs threaten to slow the deployment of new AI tools across NHS trusts and private healthcare providers, particularly for smaller organisations operating on tight budgets.
The conflict has also exposed vulnerabilities in global AI infrastructure. Iranian retaliatory strikes hit AWS facilities in the UAE and Bahrain, marking the first instance of AI data centres becoming military targets. Undersea cables connecting Gulf data facilities to Europe, Africa, and South Asia pass through the Red Sea and the Strait of Hormuz, both now effectively closed to commercial traffic. While UK-based data centres are not directly affected, the disruption to global cloud infrastructure has created latency issues and capacity constraints that affect healthcare AI services relying on distributed computing resources.
The semiconductor supply chain is under further pressure, as Taiwan and South Korea, the primary fabricators of advanced AI chips, face rising LNG costs that threaten production yields. This could delay the availability of next-generation GPUs and processors needed for healthcare AI expansion across the UK.
Government: The UK Government allocated GBP 32 million in funding for NHS AI projects across 98 initiatives and 200 organisations, and sustained investment will be critical to maintain momentum amid rising energy costs. Parliamentary briefings indicate the UK may be the worst-hit major economy from the conflict's energy price impacts, putting pressure on public health budgets allocated for AI adoption. Regulatory bodies are evaluating cybersecurity frameworks for NHS AI systems following the precedent set by military strikes on data centres in the Gulf region.
Market: The UK AI in healthcare market faces rising operational costs as data centre energy expenses increase by 30 to 50% due to the natural gas price surge driven by the conflict. Diagnostic AI and ambient clinical documentation tools, which are among the fastest-growing segments, may see slower adoption rates as NHS trusts reassess budgets amid inflationary pressures. Cloud service providers with UK-based data centre capacity are seeing increased demand as healthcare organisations seek to reduce reliance on Middle Eastern and Gulf-region infrastructure.
Procurement: NHS procurement teams are renegotiating cloud computing contracts to lock in energy surcharge caps and ensure cost predictability for AI-powered healthcare services. Technology procurement managers are evaluating on-premise AI computing alternatives to reduce dependency on cloud infrastructure routes affected by Middle Eastern disruptions. Healthcare organisations are accelerating procurement of energy-efficient AI hardware to mitigate the impact of rising electricity costs on long-term AI deployment plans.
Base Year
Historical Period
Forecast Period
In October 2025, Aide Health launched Mirror, the UK’s first AI-powered patient scribe, improving treatment adherence and reducing medical errors. Such innovations are expected to drive market growth.
A major market trend includes the development of safe and reliable AI for clinical trial design. For instance, in April 2025, Lindus Health received ARIA funding to create AI systems with mathematical safety guarantees, aiming to accelerate trials, reduce costs, and enhance accuracy in the market.
The rising adoption of AI-driven diagnostics, patient monitoring, and personalized treatment solutions by key healthcare players is accelerating innovation, improving efficiency, and driving significant growth in the market.
Compound Annual Growth Rate
36.7%
Value in USD Billion
2026-2035
*this image is indicative*
Artificial Intelligence is reshaping healthcare by enhancing clinical decision-making, improving diagnostic precision, streamlining operational workflows, and enabling more personalized patient care through advanced data analytics and real-time insights. In the United Kingdom, the market was valued at USD 11.14 Billion in 2025, and is progressing steadily, supported by strong digital infrastructure, favorable regulatory frameworks, and increasing investments in automation, predictive analytics, and patient-centric technologies across hospitals and research settings. These advancements are accelerating the adoption of AI-driven tools in diagnostics, treatment planning, and administrative optimization.
Increasing Adoption of AI-Driven Diagnostics to Accelerate the Market Expansion
The rapid adoption of advanced AI-powered diagnostic tools that enhance clinical accuracy and early disease detection is expected to be a key growth driver in the market. In April 2025, Eko Health expanded its global footprint by launching its AI-enabled digital stethoscope platform in the United Kingdom, providing clinicians nationwide access to the CORE 500™ Digital Stethoscope and Eko+ AI membership. This launch strengthens AI integration across primary care, cardiology, and community settings, supporting earlier identification of cardiovascular and respiratory conditions. Such advancements are significantly accelerating the market’s expansion and long-term value creation.
Some of the trends in the market include cross-border regulatory collaboration and the accelerated adoption of responsible AI to drive healthcare innovation.
Rising Cross-Border Regulatory Collaboration is Likely to Propel the United Kingdom AI in Healthcare Market Demand
The increasing focus on regulatory collaboration to accelerate the safe deployment of AI technologies is a prominent trend in the market. In October 2025, the UK Medicines and Healthcare products Regulatory Agency (MHRA) reinforced its partnership with the US Food and Drug Administration (FDA) to streamline approvals for AI-enabled medical devices. This collaboration aims to enhance transparency, reduce market entry barriers, and promote international regulatory alignment. Such initiatives are expected to encourage faster adoption of AI solutions across healthcare settings, strengthening innovation and driving sustained growth in the UK market.
Growing Adoption of Responsible AI Initiatives to Enhance Innovation in the United Kingdom AI in Healthcare Market
The United Kingdom is witnessing a significant shift toward the integration of responsible artificial intelligence (AI) in healthcare, aimed at enhancing patient outcomes and operational efficiency. In October 2025, HealthAI’s CEO, joined the UK National Commission on the Regulation of AI in Healthcare to advise the MHRA on establishing a robust AI regulatory framework. This initiative exemplifies the country’s commitment to safe and rapid AI deployment in clinical settings, including diagnostics and remote patient monitoring. Overall, increasing regulatory clarity and AI-enabled tools are expected to steadily accelerate the market’s growth in the coming years.
Diagnosis and Early Detection Expected to Dominate the Market Share by Function
The market is segmented by function into diagnosis and early detection, patient engagement and remote monitoring, post-treatment surveillance and survivorship care, data management and analytics, administrative, and treatment planning and personalization. Among these, diagnosis and early detection are expected to lead due to their expanding role in identifying diseases swiftly and accurately. Its growth is supported by increasing adoption of advanced screening technologies and rigorous evaluation frameworks that strengthen clinical confidence. For instance, in November 2025, City St George’s, University of London announced the world’s first platform designed to transparently and equitably assess artificial intelligence algorithms for detecting diabetic eye disease in the NHS, demonstrating these tools to be safe, fair, and highly efficient. This milestone reinforces the accelerating shift toward early detection technologies and positions the segment for sustained expansion across clinical care pathways.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by leading players. The major companies in the market are as follows:
Koninklijke Philips N.V. is a leading global health technology company offering advanced AI-enabled solutions that strengthen its presence in the market. The company offers AI-driven imaging, diagnosis, and treatment technologies, including CT Precise Image, SmartSpeed, SmartExam, PET/CT Adaptive Reconstruction, and MR AI Protocol Assistant, which enhance accuracy, speed, and workflow efficiency. Philips also delivers connected care platforms, including the AI Manager and IntelliSpace solutions, supporting clinical decision-making and care coordination. These innovations reinforce Philips’ expanding role in shaping AI-powered healthcare delivery.
Microsoft Corporation is a prominent participant in the market through its Microsoft AI for Health program, which supports global health research and innovation. The company provides advanced AI technologies for population health analytics, imaging diagnostics, and genomics, enabling improved disease prediction and clinical decision-making. Its initiatives include AI4HealthyCities, computer vision tools for early cancer detection, and AI-driven smoking cessation chatbots. By collaborating with research and nonprofit partners, Microsoft continues to strengthen its role in advancing medical research and expanding AI-enabled healthcare capabilities.
NVIDIA Corporation is a leading global provider of advanced AI computing platforms that significantly support AI in the healthcare market. Its healthcare-focused solutions, including NVIDIA DGX systems, IGX Thor robotics processors, and AI-powered imaging and genomics platforms, enable accelerated drug discovery, diagnostic imaging, and real-time medical robotics. Through collaborations with industry partners and programs such as NVIDIA Inception, the company strengthens AI innovation across life sciences, digital health, and clinical workflows, contributing to the growing adoption of AI-driven healthcare technologies worldwide.
Siemens Healthineers AG is a leading global provider of AI-powered healthcare technologies, advancing diagnostic accuracy, clinical efficiency, and patient outcomes. The company offers artificial intelligence solutions that support procedure automation, personalized care, operational streamlining, and coordinated care delivery. Its products leverage extensive datasets, advanced computing, and digital integration to improve disease prediction, therapy planning, and workflow management. With strong capabilities in healthcare AI research and deployment, Siemens Healthineers remains a key contributor to the AI in Healthcare Market, supporting healthcare organizations with scalable, data-driven innovations.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include GE Healthcare, Epic Systems Corporation, Oracle Corporation, Veradigm LLC, Medtronic plc, and Google LLC.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Offerings
Market Breakup by Function
Market Breakup by Application
Market Breakup by Deployment Mode
Market Breakup by Technology
Market Breakup by End User
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Offerings |
|
| Breakup by Function |
|
| Breakup by Application |
|
| Breakup by Deployment Mode |
|
| Breakup by Technology |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share